Free Trial
TSE:WEED

Canopy Growth Q2 2026 Earnings Results & Report

Canopy Growth logo
C$1.05 -0.03 (-2.78%)
As of 11:39 AM Eastern

Canopy Growth reported Q2 2026 earnings on November 7, 2025. The company reported EPS of -C$0.01, while revenue was $66.68 million.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
Before Market Opens

Canopy Growth EPS Results

Actual EPS
-C$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Canopy Growth Revenue Results

Actual Revenue
$66.68 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Canopy Growth Q2 2026 Earnings FAQ

Canopy Growth (TSE:WEED) reported earnings of -C$0.01 per share for Q2 2026. The report was announced on Friday, November 7, 2025.

Canopy Growth reported revenue of $66.68 million for Q2 2026.

Canopy Growth Earnings Headlines

Elon's next millionaires start October 24?
SpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into millionaires. One welder's $10,000 stock package made him a millionaire on IPO day. Former Wall Street CEO Dylan Jovine says Elon Musk's next venture could outsize everything he's built before. It runs on an obscure AI firm Musk has relied on since 2012, supplying crucial technology to Tesla, Starlink and SpaceX.tc pixel
See More Canopy Growth Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Canopy Growth? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Canopy Growth and other key companies, straight to your email.

About Canopy Growth

Canopy Growth (TSE:WEED)oration, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; and partnership with Parent Action on Drugs. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

View Canopy Growth Profile